Novartis India Limited Stock

Novartis India Limited is an India-based pure-play medicines company. The Company is focused on four core therapeutic areas: cardiovascular-renal-metabolic, immunology, neuroscience and oncology. In addition to two established technology platforms (chemistry and biotherapeutics), three emerging platforms (gene & cell therapy, radioligand therapy and xRNA) are added for continued investment into R&D and manufacturing scale. The Company’s brands hold key positions in therapeutic areas, such as, Voveran, which is the brand for bone and pain; Simulect, Certican, Sandimmun, Neoral, and Myfortic, which is the brand for transplantation immunology; and Tegrital and Exelon, which is the brand for neurosciences. Its pipeline includes AAA614 Solid tumors, AAA617 Pluvicto Oligometastatic prostate cancer, Pluvicto Metastatic hormone sensitive prostate cancer (mHSPC), 225Ac-PSMA-617 Metastatic castration-resistant prostate cancer (mCRPC), and others.